INTRODUCTION {#sec1-1}
============

Clefts of lip and palate are the most common congenital defects involving the orofacial region. The primary goal of the treatment in the cleft patients is to restore normal anatomy and function.\[[@ref1][@ref2]\]

Reconstruction of the symmetrical lip and a natural looking nose is a difficult challenge in unilateral clefts.\[[@ref3]\] Over the last two decades, the surgical technique has been improved considerably through a better understanding of the primary pathology and an integrated multidisciplinary approach.\[[@ref2][@ref4]\]

This consists of the following:

Presurgical management to reduce the initial deformityModification of surgical techniques leading to improved soft tissue as well as skeletal conditionsPost-operative management on scar care and maintenance of reconstructed nasal shapePresurgical nasoalveolar moulding (PNAM) is a non-surgical method of reshaping the alveolus, lips and nostrils before primary cleft lip and palate surgery.

PNAM addresses various problems associated with traditional methods of treating unilateral cleft lip and palate. It improves nasal asymmetry and deficient nasal tip.\[[@ref5][@ref6][@ref7]\] It also moulds the protruded premaxillary segment into a more normal alignment with the alveolar segments, improving the shape of the maxillary arch and also reducing the size of cleft lip, palate and the alveolus. It decreases the complexity of subsequent surgeries and also gives a more aesthetic outcome.\[[@ref8][@ref9][@ref10]\]

Presurgical orthopaedics has been employed since 1950 as the adjunctive procedure for correction of protruding premaxilla in the cleft. However, the original research on the neonatal moulding of the nasal cartilage was performed by Matsuo and Hirose.\[[@ref11]\] In 1993, Grayson *et al*. described a new technique of presurgical moulding of the alveolus, lip and nose in infants born with cleft lip and palate.\[[@ref12][@ref13]\] At present, there are three different PNAM techniques routinely used, namely; Grayson\'s technique,\[[@ref13]\] Figueroa\'s technique\[[@ref14]\] and Liou\'s technique.\[[@ref15]\]

It has been shown that correction of nasal cartilage deformity and non-surgical elongation of a deficient columella can be achieved in combination with moulding of alveolar process with premaxillary retraction through PNAM. This is possible because the cartilage has a high degree of plasticity in the neonatal period.\[[@ref16][@ref17]\] The temporary plasticity of cartilage is due to high levels of hyaluronic acid, a component of proteoglycan intercellular matrix,\[[@ref12][@ref18]\] which is found circulating in infants for several weeks after birth.\[[@ref19]\] Matsuo *et al*.,\[[@ref20]\] Matsuo and Hirose\[[@ref11]\] were the first to make use of this plasticity to lift nasal cartilage.

Although there have been a number of reports regarding the effectiveness of PNAM, there are hardly any prospective studies in the Indian cleft population regarding the results of PNAM and it is important to study the results of PNAM in these children with cleft lip and palate.

SUBJECTS AND METHODS {#sec1-2}
====================

This is a prospective clinical study carried out during the period between December 2011 and August 2013 in our institute.

A total of 20 unilateral cleft lip and palate patients were part of this study.

All patients were with complete unilateral cleft lip and palate (CUCLP) between the age group of 2--44 days.

Inclusion criteria {#sec2-1}
------------------

All un-operated casesNo associated syndromes and systemic illnessModerately to well-nourished healthy babies.

Exclusion criteria {#sec2-2}
------------------

Patients above 45 days of ageSyndromic, malnourished and systemically ill babiesPatient\'s/guardians who were unwilling to go through the PNAM therapy.

Following the first visit, the patients are evaluated by the surgeon and the orthodontist of the interdisciplinary cleft team. The technique followed is Liou\'s technique, wherein the alveolar and nasal mouldings are done at the same time. The PNAM device was composed of an acrylic dental plate and a nasal component. The nasal component was an extension of 20-gauge stainless steel wire along with a soft resin moulding bulb on the top \[Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\]. The dental plate was held to the palate and dental arches with the help of denture adhesives. After insertion of the dental plate, the cleft lip was digitally approximated, and the 20-gauge wire was adjusted so that the cleft side nasal cartilage was supported rather than pushed by the moulding bulb. The cleft lip was approximated by applying adhesive tapes. The tapes enabled narrowing the alveolar cleft, decreasing the width of nostrils and cinching the base of the nose.

![PNAM device- Frontal view](IJPS-49-42-g001){#F1}

![PNAM device- Lateral view view](IJPS-49-42-g002){#F2}

Through biweekly modifications on the nasal moulding bulb and adjustments to the wire, the alar cartilage was carefully moulded to resemble the normal shape. The force from the adhesive taping and counterforce from the moulding bulb provide the force necessary for bringing the alveolus into proper position. Furthermore, with regular selective removal and addition of soft liner, the alveolus was moulded.

Parents or caregivers are instructed to keep the appliance in place at all times except for daily cleaning. The therapy was done for 5--5½ months until the time of the surgery.

All the patients underwent PNAM therapy under the same orthodontist.

Photographs (worms eye view) were taken at the start and the end of the PNAM therapy.

These photographs were analysed for extraoral measurements through the Windows VistaDent software. DENTSPLY GAC INTERNATIONAL One CA Plaza, Suite 100 Islandia, NY 17149 800-645-5530 (in USA) 631-419-1700 631-357-8793 (fax) www.gacintl. com Casts of intraoral impressions at the start and the end of PNAM therapy were measured directly. The measurements were then tabulated, and a statistical analysis of the following was done of each patient.

RESULTS {#sec1-3}
=======

Photographs of the 20 patients were taken before the start of PNAM and after the completion of the PNAM therapy. These photographs were subjected to analysis, for measurements, using VistaDent software, which calculated the measurements based on the pixels \[[Table 1](#T1){ref-type="table"} and Figures [3](#F3){ref-type="fig"}--[22](#F22){ref-type="fig"}\].

###### 

Difference between cleft and noncleft side,comparison between pre- and post-surgical nasoalveolar moulding

![](IJPS-49-42-g003)

![Nostril Height (Cleft Side) Pre PNAM](IJPS-49-42-g004){#F3}

![Nostril Height (Cleft Side) Post PNAM](IJPS-49-42-g005){#F4}

![Nostril Width (Cleft Side) Pre PNAM](IJPS-49-42-g006){#F5}

![Nostril Width (Cleft Side) Post PNAM](IJPS-49-42-g007){#F6}

![Nostril Basal Width (Cleft Side) Pre PNAM](IJPS-49-42-g008){#F7}

![Nostril Basal Width (Cleft Side) Post PNAM](IJPS-49-42-g009){#F8}

![Nasal Dome Height (Cleft Side) Pre PNAM](IJPS-49-42-g010){#F9}

![Nasal Dome Height (Cleft Side) Post PNAM](IJPS-49-42-g011){#F10}

![Columella length (Cleft Side) Pre PNAM](IJPS-49-42-g012){#F11}

![Columella length (Cleft Side) Post PNAM](IJPS-49-42-g013){#F12}

![Columella Deviation (Cleft Side) Post PNAM](IJPS-49-42-g014){#F13}

![Columella Deviation (Cleft Side) Post PNAM](IJPS-49-42-g015){#F14}

![Nostril Height (Non Cleft Side) Pre PNAM](IJPS-49-42-g016){#F15}

![Nostril Height (Non Cleft Side) Post PNAM](IJPS-49-42-g017){#F16}

![Nostril Width (Non Cleft Side) Pre PNAM](IJPS-49-42-g018){#F17}

![Nostril Width (Non Cleft Side) Post PNAM](IJPS-49-42-g019){#F18}

![Nostril Basal Width (Non Cleft Side) Pre PNAM](IJPS-49-42-g020){#F19}

![Nostril Basal Width (Non Cleft Side) Post PNAM](IJPS-49-42-g021){#F20}

![Nasal Dome Height (Non Cleft Side) Pre PNAM](IJPS-49-42-g022){#F21}

![Nasal Dome Height (Non Cleft Side) Post PNAM](IJPS-49-42-g023){#F22}

Intraoral models were prepared from the impression taken before the start of PNAM and after the completion of the PNAM therapy. Direct measurements were done on the models \[[Table 1](#T1){ref-type="table"} and Figures [23](#F23){ref-type="fig"}--[25](#F25){ref-type="fig"}\].

![Inter-Alveolar Gap (A)](IJPS-49-42-g024){#F23}

![Length Of The Maxillary Alveolar Cleft (B)](IJPS-49-42-g025){#F24}

![Palatal Gap (C)](IJPS-49-42-g026){#F25}

These parameter obtained were then subjected to statistical evaluation to study the effect of PNAM, results on continuous measurements are presented as mean standard deviation (minimum-maximum). Significance has been assessed at 5% level of significance. Student\'s *t*-test has been used to find the significance of study parameters on the continuous scale within each group. Post operative results were stable at 6 m follow-up \[Figures [26](#F26){ref-type="fig"}--[29](#F29){ref-type="fig"}\].

![Immediate Post op - Frontal view](IJPS-49-42-g027){#F26}

![Immediate Post op - Worms eye view](IJPS-49-42-g028){#F27}

![6 Months Post op - Frontal View](IJPS-49-42-g029){#F28}

![6 Months Post op - Worms eye View](IJPS-49-42-g030){#F29}

DISCUSSION {#sec1-4}
==========

Millard\[[@ref21]\] described the unilateral and bilateral cleft deformity as a failure of mesenchyme to migrate from the maxillary process into the nasomedial processes. As a result of this failure, the maxilla and premaxilla do not form a bony union, and the muscle fibres from the maxillary processes do not enter the prolabium. This presents a discrepancy and a displacement of the components of nasomaxillary complex that persist without any appreciable improvement during growth.

In the case of a unilateral cleft, there is projection and outward rotation of the premaxilla along with retro-positioning of the anterior maxillary wall on the affected side. This causes flattening of the nasal tip and inferior displacement of the soft triangle.\[[@ref22]\] The nasal septum is twisted, slanted and dislocated out of the vomerine groove, resulting in a twist to the nasal tip.\[[@ref23]\] The columella is deflected by the deviation of the nasal septum and is vertically deficient on the cleft side. The deformed alar cartilage is dislodged from its normal anatomical position. The medial crus is lower in the columella, with the junction curve of the medial and lateral crus separated from the opposite alar cartilage. It rest below the opposite cartilage and is flattened, spread and stretched across the cleft at an obtuse angle.\[[@ref24][@ref25]\]

Historically, there have also been numerous attempts at a non-surgical reduction in the size of the alveolar cleft. The start of the era of modern presurgical orthopaedic appliances is usually attributed to Matsuo and Hirose.\[[@ref11]\] He utilised an intraoral acrylic appliance similar to an obturator to approximate the alveolar segments. Presurgical orthopaedic appliances have steadily evolved since then. Grayson *et al*. in 1993 first introduced the PNAM technique. Various modifications have also evolved to this technique. Moreover, now, in this study we have used Eric Liou\'s technique, which is a modification of appliance described by Grayson*et al*.

The goal of PNAM is to align and approximate the alveolar cleft segments while at the same time achieving correction of the asymmetric nasal cartilage and soft tissue deformity. These corrections are achieved by adding a nasal stent to the labial vestibular flange of a conventional intraoral moulding plate. The nasal stent and alveolar moulding plate are adjusted gradually over a period of 5--6 months to achieve nasal and alveolar symmetry, nasal tip projection, and approximation of the cleft alveolar segments before primary lip, nasal, alveolar surgical repair. The nasoalveolar orthopaedic appliance is held in place with a combination of adhesive tapes applied to the cheeks and cleft lip segments\[[@ref26]\]. The presurgical reduction in osseous and soft tissue cleft deformity considerably reduces the magnitude of the surgical challenge, resulting in improved surgical outcomes.\[[@ref19]\]

The advantages of presurgical infant orthopaedics may be considered from a soft tissue perspective as well as from the usual osseous perspective. The presurgical reduction in soft tissue and cartilaginous deformity facilitates achievement of surgical soft tissue repair under minimal tension and optimal conditions for scar formation. There is also a reduction in the number and complexity of minor soft tissue revision surgeries required to maintain acceptable nasolabial aesthetics as the nose grows.

We did this study to evaluate the outcome of PNAM in the treatment of CUCLP. The mean age at which PNAM begun was 23 days (range 2--44 days). The appliance was activated biweekly because of long distance traveling and socioeconomic status hindering the patients for regular weekly follow-ups in contrast to Liou\'s *et al*., 2004 and Grayson *et al*., 1999\[[@ref12][@ref15]\] where the moulding was done on weekly basis. A total of 24 patients started the PNAM therapy, but 4 (17%) did not continue the treatment; the reasons were, lack of compliance, socioeconomic status hindering the parents to travel and get the therapy done on regular intervals, systemic illnesses and hospitalisation not allowing the patient to continue the treatment and hence, these were excluded from the study. Our patients were at the near end of the ideal cartilage moulding period, which is determined to be first 6 weeks of life.\[[@ref18]\] The therapy was done on an average for 120 days. Both alveolar and nasal moulding were started at the same time irrespective of the alveolar ridges cleft distance, in contrast to Grayson *et al*., who starts nasal moulding when the alveolar ridges were 6 mm apart.

We found that there was a significant decrease in the nostril basal width by a mean of 4.04 mm, there was a decrease in the nostril width by a mean of 4.16 mm, the columellar length increased by mean of 2.31 mm in size at the end of the therapy which was very minimal of about 0.45 mm pre-treatment, which was statistically significant. The nasal dome height increased by mean of 3.02 mm at the end of the therapy. The nostril height increased by a mean of 2.9 mm. There was a statistically significant improvement in all aspects of soft tissue nasal deformities in this study.

Another similar study was done by Liou *et al*. 2004,\[[@ref15]\] which showed that the nostril height increased to by a mean of 2.7 mm, whereas our study showed an increase of 2.9 mm. The nasal dome height increased in their study to 2.1 mm, and it was 3.02 mm in our study, a similar trend was also seen in columellar length which was 2.8 mm in their study as compared to our minimal increase in the length of 1.8 mm. In aspects of nostril basal width, their study showed a decrease of 1.5 mm whereas in our study it was 4.04 mm and in the case of nostril width, it was decreased to 3.4 mm in their study which was almost similar to 4.1 mm decrease in our study.

Another similar study was done by Pai *et al*., 2005,\[[@ref26]\] showed that the columella deviation was increased from 53.3° to upright position of 69.9°, which is almost similar to our study which showed columella deviation moved to the midsagittal plane from 41.5° to a upright position of 61.20°.

We have compared the measurements of nostril height, nasal dome height, nostril basal width, nostril width between the cleft and the non-cleft sides, post-with pre-PNAM we found that the difference between the cleft and the non-cleft sides was much lower in the post-PNAM samples when compared to the pre-PNAM. To our knowledge, this aspect has not been reported in the literature.

Intraoral casts measurements showed that there was significant movement of the alveolar arches by a mean of 12.3 mm pre-PNAM to 4.07 thereby reducing the alveolar gap, which was similar to study by Jaeger *et al*.,\[[@ref27]\] 2007 where the alveolar gap reduction was 14.8--2.7, which was almost similar. The palatal gap also was significantly reduced to a mean of 6.88, showing a significant decrease. Patel and Goyal (2012)\[[@ref28]\] reported cleft narrowing by 7 mm after 5 month\'s treatment while Pai *et al*.\[[@ref26]\] observed a reduction of 5.8 mm after 3--4 months of treatment. The results of the present study are in concordance with these studies \[Figures [30](#F30){ref-type="fig"}--[31](#F31){ref-type="fig"}\].

![Pre PNAM Cast](IJPS-49-42-g031){#F30}

![Post PNAM Cast](IJPS-49-42-g032){#F31}

On evaluation, it was shown quantitatively that, PNAM therapy significantly reduced the alveolar and palatal gap, and deviation of columella. These, in combination, helped to align the maxillary arches. Nasal symmetry was significantly improved. Columellar length significantly improved, hence increasing the nasal aesthetics. Nostril height was significantly increased along with decreased in nostril width. All in combination improved the nasal tip projection.

CONCLUSIONS {#sec1-5}
===========

PNAM has proved to be an effective adjunctive therapy for reducing hard and soft tissue cleft deformity before surgery. However, it is important that parents or caregivers become active members of the treatment plan. This study showed that PNAM therapy improved the nasal aesthetics, decreased the cleft size and aligned the maxillary arch with a reduction in cleft alveolus and palate size in UCLCP patients. Hence, this therapy should be advocated in all patients with UCLCP patients as a routine procedure in the treatment protocol, to improve the surgical results and enhance the aesthetics and function with minimal cost and surgeries \[Figures [26](#F26){ref-type="fig"}--[29](#F29){ref-type="fig"}\].
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